Patent details

Basic Information

Publication number:

EP3092256

PCT Application Number:

CN2015070379

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157348491

PCT Publication Number:

WO2015103989

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY

French Title of Invention:

COMPOSÉS ET COMPOSITIONS POUR L'IMMUNOTHÉRAPIE

German Title of Invention:

VERBINDUNGEN UND ZUSAMMENSETZUNGEN FÜR DIE IMMUNTHERAPIE

SPC Number:

Dates

Filing date:

08/01/2015

Grant date:

18/05/2022

EP Publication Date:

16/11/2016

PCT Publication Date:

16/07/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/05/2022

EP B1 Publication Date:

18/05/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/01/2023

Expiration date:

08/01/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/05/2022

 

 

Name:

Birdie Biopharmaceuticals Inc.

Address:

Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay, Grand Cayman, Cayman Islands (KY)

Inventor

Name:

LI, Lixin

Address:

China (CN)

Priority

1

Priority Number:

201410011362

Priority Date:

10/01/2014

Priority Country:

China (CN)

2

Priority Number:

201410011262

Priority Date:

10/01/2014

Priority Country:

China (CN)

3

Priority Number:

201410011324

Priority Date:

10/01/2014

Priority Country:

China (CN)

Classification

IPC classification:

C07K 16/32; A61K 31/4745; A61K 31/522; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:

202220

Publication date:

18/05/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages